EVENTIDE ASSET MANAGEMENT, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$7.4B
Holdings
152
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (152 positions)
| Stock | Value |
|---|---|
CRWDCROWDSTRIKE HLDGS INC | $224.0B |
ASNDASCENDIS PHARMA A/S | $223.5B |
FIVNFIVE9 INC | $216.5B |
EXASEXACT SCIENCES CORP | $216.3B |
TTDTHE TRADE DESK INC | $213.2B |
—BIOHAVEN PHARMACTL HLDG CO L | $193.3B |
DTDYNATRACE INC | $159.5B |
MTDMETTLER TOLEDO INTERNATIONAL | $155.2B |
TWLOTWILIO INC | $155.1B |
IDXXIDEXX LABS INC | $151.6B |
ROPROPER TECHNOLOGIES INC | $146.9B |
HUBSHUBSPOT INC | $138.7B |
LRCXEURLAM RESEARCH CORP | $133.0B |
GNRCGENERAC HLDGS INC | $131.1B |
FVRRFIVERR INTL LTD | $130.9B |
ASMLASML HOLDING N V | $118.8B |
TTTRANE TECHNOLOGIES PLC | $116.7B |
POOLPOOL CORP | $115.5B |
ODFLOLD DOMINION FREIGHT LINE IN | $112.2B |
—ZYMEWORKS INC | $111.0B |
CITCINTAS CORP | $110.6B |
WWAYFAIR INC | $105.3B |
XIFRNEXTERA ENERGY PARTNERS LP | $101.3B |
GTMZOOMINFO TECHNOLOGIES INC | $101.3B |
ARGXARGENX SE | $100.3B |
LOWLOWES COS INC | $96.9B |
WCNWASTE CONNECTIONS INC | $96.0B |
DHID R HORTON INC | $95.4B |
TREURTRILLIUM THERAPEUTICS INC | $92.2B |
SPTSPROUT SOCIAL INC | $90.5B |
TREXTREX CO INC | $90.1B |
—PROMETHEUS BIOSCIENCES INC | $88.2B |
RNGRINGCENTRAL INC | $87.9B |
KRTXKARUNA THERAPEUTICS INC | $85.3B |
APTVAPTIV PLC | $84.5B |
ENQENTEGRIS INC | $80.1B |
MGAMAGNA INTL INC | $75.6B |
PLRXPLIANT THERAPEUTICS INC | $72.0B |
TCE2CELLDEX THERAPEUTICS INC NEW | $70.5B |
EPIEURESSA PHARMA INC | $68.7B |
PRAXPRAXIS PRECISION MEDICINES I | $67.7B |
YETIYETI HLDGS INC | $63.4B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $62.2B |
8CWCROWN CASTLE INTL CORP NEW | $61.1B |
VITLVITAL FARMS INC | $60.0B |
PANWPALO ALTO NETWORKS INC | $55.4B |
TSMTAIWAN SEMICONDUCTOR MFG LTD | $54.4B |
ANNXANNEXON INC | $53.3B |
SHLSSHOALS TECHNOLOGIES GROUP IN | $51.4B |
DDOGDATADOG INC | $50.5B |
SMARGBPSMARTSHEET INC | $50.3B |
MAXMEDIAALPHA INC | $50.1B |
BEPBROOKFIELD RENEWABLE PARTNER | $47.7B |
—TURNING POINT THERAPEUTICS I | $45.1B |
STROSUTRO BIOPHARMA INC | $44.1B |
BBIOBRIDGEBIO PHARMA INC | $43.4B |
2L9BLUEPRINT MEDICINES CORP | $40.6B |
NCNO*NCINO INC | $39.7B |
HASIHANNON ARMSTRONG SUST INFR C | $39.3B |
BEPCBROOKFIELD RENEWABLE CORP | $38.1B |
1GSNNOVANTA INC | $37.7B |
VRSKVERISK ANALYTICS INC | $37.2B |
CGEMCULLINAN ONCOLOGY INC | $36.2B |
IMVTIMMUNOVANT INC | $35.6B |
BCYCBICYCLE THERAPEUTICS PLC | $35.3B |
CWENCLEARWAY ENERGY INC | $34.5B |
ALLKGUSDALLAKOS INC | $34.2B |
LIILENNOX INTL INC | $33.3B |
MDBMONGODB INC | $32.3B |
ADCTADC THERAPEUTICS SA | $31.9B |
NRIXNURIX THERAPEUTICS INC | $31.8B |
XPOXPO LOGISTICS INC | $30.8B |
CGNXCOGNEX CORP | $30.2B |
MPWRMONOLITHIC PWR SYS INC | $28.9B |
AWMSKYWORKS SOLUTIONS INC | $28.4B |
XENEXENON PHARMACEUTICALS INC | $27.7B |
—VECTIVBIO HLDG AG | $26.6B |
COMPCOMPASS INC | $26.6B |
VCYTVERACYTE INC | $26.0B |
ROLROLLINS INC | $24.9B |
ALXOALX ONCOLOGY HLDGS INC | $24.1B |
BYNDBEYOND MEAT INC | $24.0B |
CRDFCARDIFF ONCOLOGY INC | $23.8B |
RGENREPLIGEN CORP | $23.8B |
ISRGINTUITIVE SURGICAL INC | $23.0B |
NBIXNEUROCRINE BIOSCIENCES INC | $22.9B |
AG8AGILENT TECHNOLOGIES INC | $22.4B |
—TALARIS THERAPEUTICS INC | $22.4B |
ZNTLZENTALIS PHARMACEUTICALS INC | $22.4B |
ETNBGBP89BIO INC | $21.3B |
SHCSOTERA HEALTH CO | $21.1B |
MRTXEURMIRATI THERAPEUTICS INC | $20.9B |
PHATPHATHOM PHARMACEUTICALS INC | $20.3B |
BFLYBUTTERFLY NETWORK INC | $19.8B |
—FREELINE THERAPEUTICS HLDGS | $19.8B |
CCXIEURCHEMOCENTRYX INC | $18.8B |
FRCBFIRST REP BK SAN FRANCISCO C | $18.5B |
STESTERIS PLC | $18.3B |
KROSKEROS THERAPEUTICS INC | $18.2B |
NVTNVENT ELECTRIC PLC | $17.5B |
Page 1 of 2Next